In:
Annals of the New York Academy of Sciences, Wiley, Vol. 1188, No. 1 ( 2010-02), p. 68-77
Abstract:
Because previous findings showed that in human embryonic stem cell–derived cardiomyocytes (hESC‐CM) the machinery for Ca 2+ ‐induced release of calcium is immature, we tested the hypothesis that hESC‐CM contain functional 1,4,5‐inositol triphosphate (IP 3 )–operated intracellular Ca 2+ ([Ca 2+ ] i ) stores. We investigated the effects of angiotensin II (AT‐II) and endothelin 1 (ET‐1), which activate the 1,4,5‐IP 3 pathway, on [Ca 2+ ] i transients and contractions in hESC‐CM. Our major findings were that in hESC‐CM, both AT‐II (10 −9 –10 −7 M) and ET‐1 (10 −9 –10 −7 M) exert inotropic and lusitropic effects. The involvement of 1,4,5‐IP 3 ‐dependent intracellular Ca 2+ release in AT‐I–induced effects was supported by these findings: the effects of AT‐II were blocked by 2‐aminoethoxyphenyl borate (2‐APB, a 1,4,5‐IP 3 receptor blocker) and U73122 (a phosopholipase C blocker); and hESC‐CM express AT‐II type 1 and IP 3 type I and II receptors as determined by fluorescence immunostaining. In conclusion, hESC‐CM exhibit functional AT‐II and ET‐1 signaling pathways, as well as 1,4,5‐IP 3 –operated releasable Ca 2+ stores.
Type of Medium:
Online Resource
ISSN:
0077-8923
,
1749-6632
DOI:
10.1111/nyas.2010.1188.issue-1
DOI:
10.1111/j.1749-6632.2009.05085.x
Language:
English
Publisher:
Wiley
Publication Date:
2010
detail.hit.zdb_id:
2834079-6
detail.hit.zdb_id:
211003-9
detail.hit.zdb_id:
2071584-5
SSG:
11
Permalink